Plasma Biomarkers in Graft-versus-Host Disease: A New Era?

Sophie Paczesny, John E. Levine, Thomas M. Braun, James L M Ferrara

Research output: Contribution to journalArticle

38 Citations (Scopus)

Abstract

Acute graft versus host disease (GVHD) remains a major complication of allogeneic hematopoietic cell transplantation (HCT). The diagnosis of acute GVHD is based on strictly clinical criteria and its severity also determined by these criteria. Currently, there is no validated diagnostic blood test for acute GVHD. This review will summarize proteomics approaches to identify biomarkers for GVHD in the plasma with diagnostic, prognostic and predictive value. If successful, these studies could establish a novel biomarker panel that will contribute important information including long term survival, and that may eventually facilitate therapeutic decisions for allogeneic HCT patients.

Original languageEnglish (US)
Pages (from-to)33-38
Number of pages6
JournalBiology of Blood and Marrow Transplantation
Volume15
Issue number1 SUPPL.
DOIs
StatePublished - Jan 2009
Externally publishedYes

Fingerprint

Graft vs Host Disease
Biomarkers
Cell Transplantation
Hematologic Tests
Routine Diagnostic Tests
Proteomics
Survival
Therapeutics

Keywords

  • biomarkers panel
  • Graft versus host disease
  • plasma biomarker
  • proteomics

ASJC Scopus subject areas

  • Transplantation
  • Hematology

Cite this

Plasma Biomarkers in Graft-versus-Host Disease : A New Era? / Paczesny, Sophie; Levine, John E.; Braun, Thomas M.; Ferrara, James L M.

In: Biology of Blood and Marrow Transplantation, Vol. 15, No. 1 SUPPL., 01.2009, p. 33-38.

Research output: Contribution to journalArticle

Paczesny, Sophie ; Levine, John E. ; Braun, Thomas M. ; Ferrara, James L M. / Plasma Biomarkers in Graft-versus-Host Disease : A New Era?. In: Biology of Blood and Marrow Transplantation. 2009 ; Vol. 15, No. 1 SUPPL. pp. 33-38.
@article{acf35734447040288eac78619efc2324,
title = "Plasma Biomarkers in Graft-versus-Host Disease: A New Era?",
abstract = "Acute graft versus host disease (GVHD) remains a major complication of allogeneic hematopoietic cell transplantation (HCT). The diagnosis of acute GVHD is based on strictly clinical criteria and its severity also determined by these criteria. Currently, there is no validated diagnostic blood test for acute GVHD. This review will summarize proteomics approaches to identify biomarkers for GVHD in the plasma with diagnostic, prognostic and predictive value. If successful, these studies could establish a novel biomarker panel that will contribute important information including long term survival, and that may eventually facilitate therapeutic decisions for allogeneic HCT patients.",
keywords = "biomarkers panel, Graft versus host disease, plasma biomarker, proteomics",
author = "Sophie Paczesny and Levine, {John E.} and Braun, {Thomas M.} and Ferrara, {James L M}",
year = "2009",
month = "1",
doi = "10.1016/j.bbmt.2008.10.027",
language = "English (US)",
volume = "15",
pages = "33--38",
journal = "Biology of Blood and Marrow Transplantation",
issn = "1083-8791",
publisher = "Elsevier Inc.",
number = "1 SUPPL.",

}

TY - JOUR

T1 - Plasma Biomarkers in Graft-versus-Host Disease

T2 - A New Era?

AU - Paczesny, Sophie

AU - Levine, John E.

AU - Braun, Thomas M.

AU - Ferrara, James L M

PY - 2009/1

Y1 - 2009/1

N2 - Acute graft versus host disease (GVHD) remains a major complication of allogeneic hematopoietic cell transplantation (HCT). The diagnosis of acute GVHD is based on strictly clinical criteria and its severity also determined by these criteria. Currently, there is no validated diagnostic blood test for acute GVHD. This review will summarize proteomics approaches to identify biomarkers for GVHD in the plasma with diagnostic, prognostic and predictive value. If successful, these studies could establish a novel biomarker panel that will contribute important information including long term survival, and that may eventually facilitate therapeutic decisions for allogeneic HCT patients.

AB - Acute graft versus host disease (GVHD) remains a major complication of allogeneic hematopoietic cell transplantation (HCT). The diagnosis of acute GVHD is based on strictly clinical criteria and its severity also determined by these criteria. Currently, there is no validated diagnostic blood test for acute GVHD. This review will summarize proteomics approaches to identify biomarkers for GVHD in the plasma with diagnostic, prognostic and predictive value. If successful, these studies could establish a novel biomarker panel that will contribute important information including long term survival, and that may eventually facilitate therapeutic decisions for allogeneic HCT patients.

KW - biomarkers panel

KW - Graft versus host disease

KW - plasma biomarker

KW - proteomics

UR - http://www.scopus.com/inward/record.url?scp=64749090787&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=64749090787&partnerID=8YFLogxK

U2 - 10.1016/j.bbmt.2008.10.027

DO - 10.1016/j.bbmt.2008.10.027

M3 - Article

C2 - 19147075

AN - SCOPUS:64749090787

VL - 15

SP - 33

EP - 38

JO - Biology of Blood and Marrow Transplantation

JF - Biology of Blood and Marrow Transplantation

SN - 1083-8791

IS - 1 SUPPL.

ER -